Study protocol and rationale for a randomized, placebo-controlled trial of solriamfetol to treat binge eating disorder.
| Author | |
|---|---|
| Abstract |
:
Binge eating disorder (BED) is an important public health problem associated with severe psychosocial and medical consequences for which treatment options are limited. The objective of this study is to evaluate the efficacy and tolerability of the novel dopamine and norepinephrine reuptake inhibitor (DNRI) solriamfetol in the treatment of BED. |
| Year of Publication |
:
2021
|
| Journal |
:
Contemporary clinical trials
|
| Volume |
:
110
|
| Number of Pages |
:
106587
|
| ISSN Number |
:
1551-7144
|
| URL |
:
https://linkinghub.elsevier.com/retrieve/pii/S1551-7144(21)00323-2
|
| DOI |
:
10.1016/j.cct.2021.106587
|
| Short Title |
:
Contemp Clin Trials
|
| Download citation |
